Literature DB >> 24798221

Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy.

Donovan J Lott1, Sean C Forbes2, Sunita Mathur3, Sean A Germain4, Claudia R Senesac2, H Lee Sweeney5, Glenn A Walter6, Krista Vandenborne2.   

Abstract

The purpose of this study was to use proton magnetic resonance spectroscopy to assess intramuscular lipid and metabolites of lower leg muscles in boys with Duchenne muscular dystrophy (DMD) and determine its relationship with strength and functional ability. Spectroscopic measurements were obtained from four muscles of the lower leg in 25 boys with DMD (9.2±3.1 years) and 10 healthy boys (10.2±2.6 years). Lipid fractions and metabolite concentrations were also determined. Muscle strength, a timed functional test, and the Modified Brooke Lower Extremity Functional Scale were also determined. Lipid fractions were higher (p<0.01) for the DMD group than healthy subjects for all muscles, and lipid fraction was found to be greater in the older DMD boys. The peroneal muscle demonstrated a significant difference in lipid fraction in all DMD age groups. Lipid fractions in all muscles correlated with functional measures (r=0.52-0.70, p<0.001), with smaller inverse correlations with the strength measure (r=-0.36 to -0.56, p<0.05). These findings provide quantifiable information regarding intramuscular lipid and metabolite levels of different muscles across various age groups in boys with DMD and may be used in determining the effect of interventions in future clinical trials.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Duchenne muscular dystrophy; Lipid fraction; Metabolite; Spectroscopy

Mesh:

Year:  2014        PMID: 24798221      PMCID: PMC4142654          DOI: 10.1016/j.nmd.2014.03.013

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  56 in total

1.  Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.

Authors:  Birol Balaban; Dennis J Matthews; Gerald H Clayton; Terri Carry
Journal:  Am J Phys Med Rehabil       Date:  2005-11       Impact factor: 2.159

2.  Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging.

Authors:  Franklin A Marden; Anne M Connolly; Marilyn J Siegel; David A Rubin
Journal:  Skeletal Radiol       Date:  2004-10-22       Impact factor: 2.199

Review 3.  Gait and posture changes in the Duchenne muscular dystrophy child.

Authors:  J D Hsu; J Furumasu
Journal:  Clin Orthop Relat Res       Date:  1993-03       Impact factor: 4.176

4.  Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.

Authors:  W D Biggar; V A Harris; L Eliasoph; B Alman
Journal:  Neuromuscul Disord       Date:  2006-03-20       Impact factor: 4.296

5.  Profiles of neuromuscular diseases. Duchenne muscular dystrophy.

Authors:  C M McDonald; R T Abresch; G T Carter; W M Fowler; E R Johnson; D D Kilmer; B J Sigford
Journal:  Am J Phys Med Rehabil       Date:  1995 Sep-Oct       Impact factor: 2.159

6.  Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy.

Authors:  M H Brooke; G M Fenichel; R C Griggs; J R Mendell; R Moxley; J Florence; W M King; S Pandya; J Robison; J Schierbecker
Journal:  Neurology       Date:  1989-04       Impact factor: 9.910

7.  Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy.

Authors:  Y Huang; S Majumdar; H K Genant; W P Chan; K R Sharma; P Yu; M Mynhier; R G Miller
Journal:  J Magn Reson Imaging       Date:  1994 Jan-Feb       Impact factor: 4.813

8.  Duchenne muscular dystrophy: MR grading system with functional correlation.

Authors:  G C Liu; Y J Jong; C H Chiang; T S Jaw
Journal:  Radiology       Date:  1993-02       Impact factor: 11.105

9.  Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.

Authors:  G M Fenichel; J M Florence; A Pestronk; J R Mendell; R T Moxley; R C Griggs; M H Brooke; J P Miller; J Robison; W King
Journal:  Neurology       Date:  1991-12       Impact factor: 9.910

10.  Deflazacort in Duchenne dystrophy: study of long-term effect.

Authors:  C Angelini; E Pegoraro; E Turella; M T Intino; A Pini; C Costa
Journal:  Muscle Nerve       Date:  1994-04       Impact factor: 3.217

View more
  15 in total

1.  Age-dependent changes in metabolite profile and lipid saturation in dystrophic mice.

Authors:  Brittany Lee-McMullen; Stephen M Chrzanowski; Ravneet Vohra; Sean C Forbes; Krista Vandenborne; Arthur S Edison; Glenn A Walter
Journal:  NMR Biomed       Date:  2019-03-08       Impact factor: 4.044

2.  Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort.

Authors:  Rebecca J Willcocks; William D Rooney; William T Triplett; Sean C Forbes; Donovan J Lott; Claudia R Senesac; Michael J Daniels; Dah-Jyuu Wang; Ann T Harrington; Gihan I Tennekoon; Barry S Russman; Erika L Finanger; Barry J Byrne; Richard S Finkel; Glenn A Walter; H Lee Sweeney; Krista Vandenborne
Journal:  Ann Neurol       Date:  2016-02-19       Impact factor: 10.422

3.  Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.

Authors:  Claudia R Senesac; Donovan J Lott; Sean C Forbes; Sunita Mathur; Ishu Arpan; Emily S Senesac; Glenn A Walter; Krista Vandenborne
Journal:  Phys Ther       Date:  2015-01-15

4.  Step Activity Monitoring in Boys with Duchenne Muscular Dystrophy and its Correlation with Magnetic Resonance Measures and Functional Performance.

Authors:  Kavya S Nair; Donovan J Lott; Sean C Forbes; Alison M Barnard; Rebecca J Willcocks; Claudia R Senesac; Michael J Daniels; Ann T Harrington; Gihan I Tennekoon; Kirsten Zilke; Erika L Finanger; Richard S Finkel; William D Rooney; Glenn A Walter; Krista Vandenborne
Journal:  J Neuromuscul Dis       Date:  2022

5.  Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic program.

Authors:  Alexander Morrison-Nozik; Priti Anand; Han Zhu; Qiming Duan; Mohamad Sabeh; Domenick A Prosdocimo; Madeleine E Lemieux; Nikolai Nordsborg; Aaron P Russell; Calum A MacRae; Anthony N Gerber; Mukesh K Jain; Saptarsi M Haldar
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

Review 6.  Immune-mediated pathology in Duchenne muscular dystrophy.

Authors:  Amy S Rosenberg; Montserrat Puig; Kanneboyina Nagaraju; Eric P Hoffman; S Armando Villalta; V Ashutosh Rao; Lalage M Wakefield; Janet Woodcock
Journal:  Sci Transl Med       Date:  2015-08-05       Impact factor: 17.956

7.  Postcontractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy.

Authors:  Christopher Lopez; Tanja Taivassalo; Maria G Berru; Andres Saavedra; Hannah C Rasmussen; Abhinandan Batra; Harneet Arora; Alex M Roetzheim; Glenn A Walter; Krista Vandenborne; Sean C Forbes
Journal:  J Appl Physiol (1985)       Date:  2021-05-20

8.  Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study.

Authors:  Abhinandan Batra; Donovan J Lott; Rebecca Willcocks; Sean C Forbes; William Triplett; Jahannaz Dastgir; Pomi Yun; A Reghan Foley; Carsten G Bönnemann; Krista Vandenborne; Glenn A Walter
Journal:  J Neuromuscul Dis       Date:  2020

9.  Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study.

Authors:  Sean C Forbes; Rebecca J Willcocks; William T Triplett; William D Rooney; Donovan J Lott; Dah-Jyuu Wang; Jim Pollaro; Claudia R Senesac; Michael J Daniels; Richard S Finkel; Barry S Russman; Barry J Byrne; Erika L Finanger; Gihan I Tennekoon; Glenn A Walter; H Lee Sweeney; Krista Vandenborne
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

10.  Quercetin inhibits adipogenesis of muscle progenitor cells in vitro.

Authors:  Tomoko Funakoshi; Noriyuki Kanzaki; Yuta Otsuka; Takayuki Izumo; Hiroshi Shibata; Shuichi Machida
Journal:  Biochem Biophys Rep       Date:  2017-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.